Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	1-phosphatidylinositol-4-phosphate 3-kinase activity	PIK3C2A PIK3C2B	2.66e-05	7	23	2	GO:0035005
GeneOntologyMolecularFunction	extracellular matrix structural constituent	MUC5AC LTBP1 VWF TECTA	5.86e-05	188	23	4	GO:0005201
GeneOntologyMolecularFunction	1-phosphatidylinositol-3-kinase activity	PIK3C2A PIK3C2B	6.94e-05	11	23	2	GO:0016303
GeneOntologyMolecularFunction	phosphatidylinositol kinase activity	PIK3C2A PIK3C2B	4.06e-04	26	23	2	GO:0052742
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	CHD3 CHD4	8.25e-04	37	23	2	GO:0140658
GeneOntologyMolecularFunction	lipid kinase activity	PIK3C2A PIK3C2B	1.01e-03	41	23	2	GO:0001727
GeneOntologyMolecularFunction	integrin binding	TNR CASR VWF	1.03e-03	175	23	3	GO:0005178
GeneOntologyCellularComponent	extracellular matrix	TNR SNED1 MUC5AC LTBP1 VWF TECTA	5.97e-05	656	23	6	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	TNR SNED1 MUC5AC LTBP1 VWF TECTA	6.07e-05	658	23	6	GO:0030312
GeneOntologyCellularComponent	NuRD complex	CHD3 CHD4	1.56e-04	17	23	2	GO:0016581
GeneOntologyCellularComponent	CHD-type complex	CHD3 CHD4	1.56e-04	17	23	2	GO:0090545
GeneOntologyCellularComponent	phosphatidylinositol 3-kinase complex	PIK3C2A PIK3C2B	4.62e-04	29	23	2	GO:0005942
GeneOntologyCellularComponent	histone deacetylase complex	CHD3 CHD4	3.91e-03	85	23	2	GO:0000118
MousePheno	abnormal circulating phosphate level	PIK3C2A TNR CASR ENPP1 CHD3	1.51e-05	260	18	5	MP:0001565
MousePheno	abnormal phosphate level	PIK3C2A TNR CASR ENPP1 CHD3	1.56e-05	262	18	5	MP:0020885
MousePheno	calcinosis	CASR ENPP1	4.36e-05	8	18	2	MP:0003195
MousePheno	decreased circulating mineral level	PCSK5 CASR ENPP1 CHD3 LTBP1	1.06e-04	391	18	5	MP:0014548
MousePheno	abnormal circulating mineral level	PCSK5 PIK3C2A TNR CASR ENPP1 CHD3 LTBP1	1.32e-04	982	18	7	MP:0006357
MousePheno	decreased mineral level	PCSK5 CASR ENPP1 CHD3 LTBP1	1.50e-04	421	18	5	MP:0014536
MousePheno	decreased circulating phosphate level	CASR ENPP1 CHD3	2.16e-04	93	18	3	MP:0000198
MousePheno	abnormal mineral level	PCSK5 PIK3C2A TNR CASR ENPP1 CHD3 LTBP1	2.21e-04	1066	18	7	MP:0000192
MousePheno	decreased phosphate level	CASR ENPP1 CHD3	2.23e-04	94	18	3	MP:0014546
MousePheno	abnormal mineral homeostasis	PCSK5 PIK3C2A TNR CASR ENPP1 CHD3 LTBP1	2.35e-04	1076	18	7	MP:0005636
MousePheno	nephrocalcinosis	CASR ENPP1	2.93e-04	20	18	2	MP:0003197
MousePheno	increased hemoglobin content	AFM LTBP1 VWF	3.84e-04	113	18	3	MP:0005564
MousePheno	abnormal knee morphology	PCSK5 ENPP1	3.90e-04	23	18	2	MP:0030881
MousePheno	abnormal ion homeostasis	PCSK5 PIK3C2A TNR CASR ENPP1 CHD3 LTBP1	5.41e-04	1232	18	7	MP:0001765
MousePheno	abnormal coronary artery morphology	ENPP1 LTBP1	6.23e-04	29	18	2	MP:0004111
MousePheno	abnormal appendicular skeleton morphology	PCSK5 CASR ENPP1 LTBP1 CHD4 AASDH	6.49e-04	896	18	6	MP:0009250
MousePheno	decreased susceptibility to induced thrombosis	PIK3C2A VWF	6.67e-04	30	18	2	MP:0031120
MousePheno	increased susceptibility to otitis media	ENPP1 KIF27	7.12e-04	31	18	2	MP:0001850
MousePheno	vascular ring	PCSK5 LTBP1	9.09e-04	35	18	2	MP:0010466
MousePheno	increased width of hypertrophic chondrocyte zone	CASR CHD4	1.13e-03	39	18	2	MP:0003408
MousePheno	ear inflammation	ENPP1 KIF27	1.19e-03	40	18	2	MP:0001849
MousePheno	abnormal cartilage development	CASR ENPP1 CHD4	1.30e-03	172	18	3	MP:0000164
MousePheno	abnormal long bone morphology	PCSK5 CASR ENPP1 LTBP1 CHD4	1.32e-03	676	18	5	MP:0003723
MousePheno	abnormal forelimb morphology	PCSK5 ENPP1 LTBP1	1.53e-03	182	18	3	MP:0000550
MousePheno	abnormal hemoglobin content	PIK3C2A AFM LTBP1 VWF	1.58e-03	408	18	4	MP:0005563
Domain	TIL	MUC5AC VWF TECTA	3.56e-07	12	23	3	PF01826
Domain	C8	MUC5AC VWF TECTA	3.56e-07	12	23	3	PF08742
Domain	Unchr_dom_Cys-rich	MUC5AC VWF TECTA	4.63e-07	13	23	3	IPR014853
Domain	C8	MUC5AC VWF TECTA	4.63e-07	13	23	3	SM00832
Domain	TIL_dom	MUC5AC VWF TECTA	5.89e-07	14	23	3	IPR002919
Domain	VWFD	MUC5AC VWF TECTA	9.04e-07	16	23	3	PS51233
Domain	VWD	MUC5AC VWF TECTA	9.04e-07	16	23	3	SM00216
Domain	VWF_type-D	MUC5AC VWF TECTA	9.04e-07	16	23	3	IPR001846
Domain	VWD	MUC5AC VWF TECTA	9.04e-07	16	23	3	PF00094
Domain	VWC_out	MUC5AC VWF TECTA	1.56e-06	19	23	3	SM00215
Domain	CHDCT2	CHD3 CHD4	4.35e-06	3	23	2	PF08074
Domain	CHDNT	CHD3 CHD4	4.35e-06	3	23	2	PF08073
Domain	DUF1086	CHD3 CHD4	4.35e-06	3	23	2	IPR009462
Domain	DUF1087	CHD3 CHD4	4.35e-06	3	23	2	IPR009463
Domain	DUF1087	CHD3 CHD4	4.35e-06	3	23	2	PF06465
Domain	DUF1086	CHD3 CHD4	4.35e-06	3	23	2	PF06461
Domain	DUF1087	CHD3 CHD4	4.35e-06	3	23	2	SM01147
Domain	DUF1086	CHD3 CHD4	4.35e-06	3	23	2	SM01146
Domain	CHD_N	CHD3 CHD4	4.35e-06	3	23	2	IPR012958
Domain	CHD_C2	CHD3 CHD4	4.35e-06	3	23	2	IPR012957
Domain	EGF	PCSK5 TNR SNED1 LTBP1 TECTA	8.45e-06	235	23	5	SM00181
Domain	EGF-like_dom	PCSK5 TNR SNED1 LTBP1 TECTA	1.12e-05	249	23	5	IPR000742
Domain	VWC	MUC5AC VWF TECTA	1.34e-05	38	23	3	SM00214
Domain	VWFC_2	MUC5AC VWF TECTA	1.34e-05	38	23	3	PS50184
Domain	NIDO_dom	SNED1 TECTA	1.45e-05	5	23	2	IPR003886
Domain	NIDO	SNED1 TECTA	1.45e-05	5	23	2	PS51220
Domain	NIDO	SNED1 TECTA	1.45e-05	5	23	2	SM00539
Domain	NIDO	SNED1 TECTA	1.45e-05	5	23	2	PF06119
Domain	VWF_dom	MUC5AC VWF TECTA	1.81e-05	42	23	3	IPR001007
Domain	PI3K_Ras-bd_dom	PIK3C2A PIK3C2B	3.03e-05	7	23	2	IPR000341
Domain	PI3K_RBD	PIK3C2A PIK3C2B	3.03e-05	7	23	2	PS51546
Domain	PI3K_rbd	PIK3C2A PIK3C2B	3.03e-05	7	23	2	SM00144
Domain	PI3K_rbd	PIK3C2A PIK3C2B	3.03e-05	7	23	2	PF00794
Domain	PI3K_C2_dom	PIK3C2A PIK3C2B	4.04e-05	8	23	2	IPR002420
Domain	PI3K_C2	PIK3C2A PIK3C2B	4.04e-05	8	23	2	PS51547
Domain	PI3K_C2	PIK3C2A PIK3C2B	4.04e-05	8	23	2	SM00142
Domain	PI3K_C2	PIK3C2A PIK3C2B	4.04e-05	8	23	2	PF00792
Domain	PI3Ka	PIK3C2A PIK3C2B	5.19e-05	9	23	2	PF00613
Domain	-	PIK3C2A PIK3C2B	5.19e-05	9	23	2	1.25.40.70
Domain	PI3Ka	PIK3C2A PIK3C2B	5.19e-05	9	23	2	SM00145
Domain	PIK_HELICAL	PIK3C2A PIK3C2B	6.49e-05	10	23	2	PS51545
Domain	PI_Kinase	PIK3C2A PIK3C2B	6.49e-05	10	23	2	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3C2A PIK3C2B	6.49e-05	10	23	2	IPR001263
Domain	Zinc_finger_PHD-type_CS	KDM2A CHD3 CHD4	6.78e-05	65	23	3	IPR019786
Domain	Znf_PHD-finger	KDM2A CHD3 CHD4	1.21e-04	79	23	3	IPR019787
Domain	PI3/4_kinase_CS	PIK3C2A PIK3C2B	1.51e-04	15	23	2	IPR018936
Domain	PI3Kc	PIK3C2A PIK3C2B	1.72e-04	16	23	2	SM00146
Domain	-	PIK3C2A PIK3C2B	1.72e-04	16	23	2	1.10.1070.11
Domain	PHD	KDM2A CHD3 CHD4	1.73e-04	89	23	3	SM00249
Domain	Znf_PHD	KDM2A CHD3 CHD4	1.85e-04	91	23	3	IPR001965
Domain	ZF_PHD_2	KDM2A CHD3 CHD4	2.10e-04	95	23	3	PS50016
Domain	ZF_PHD_1	KDM2A CHD3 CHD4	2.16e-04	96	23	3	PS01359
Domain	CTCK_1	MUC5AC VWF	2.19e-04	18	23	2	PS01185
Domain	PI3_4_KINASE_1	PIK3C2A PIK3C2B	2.19e-04	18	23	2	PS00915
Domain	PI3_4_KINASE_2	PIK3C2A PIK3C2B	2.19e-04	18	23	2	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3C2A PIK3C2B	2.19e-04	18	23	2	IPR000403
Domain	PI3_PI4_kinase	PIK3C2A PIK3C2B	2.19e-04	18	23	2	PF00454
Domain	PI3_4_KINASE_3	PIK3C2A PIK3C2B	2.19e-04	18	23	2	PS50290
Domain	CT	MUC5AC VWF	3.30e-04	22	23	2	SM00041
Domain	Chromo_domain	CHD3 CHD4	3.94e-04	24	23	2	IPR023780
Domain	Cys_knot_C	MUC5AC VWF	4.28e-04	25	23	2	IPR006207
Domain	CTCK_2	MUC5AC VWF	4.28e-04	25	23	2	PS01225
Domain	Chromo	CHD3 CHD4	4.63e-04	26	23	2	PF00385
Domain	EGF	SNED1 LTBP1 TECTA	4.81e-04	126	23	3	PF00008
Domain	CHROMO_2	CHD3 CHD4	5.38e-04	28	23	2	PS50013
Domain	CHROMO_1	CHD3 CHD4	5.38e-04	28	23	2	PS00598
Domain	VWC	MUC5AC VWF	5.38e-04	28	23	2	PF00093
Domain	SNF2_N	CHD3 CHD4	7.04e-04	32	23	2	PF00176
Domain	SNF2_N	CHD3 CHD4	7.04e-04	32	23	2	IPR000330
Domain	Chromodomain-like	CHD3 CHD4	7.04e-04	32	23	2	IPR016197
Domain	CHROMO	CHD3 CHD4	7.48e-04	33	23	2	SM00298
Domain	Chromo/shadow_dom	CHD3 CHD4	7.48e-04	33	23	2	IPR000953
Domain	Znf_FYVE_PHD	KDM2A CHD3 CHD4	7.54e-04	147	23	3	IPR011011
Domain	DNA/RNA_helicase_DEAH_CS	CHD3 CHD4	8.42e-04	35	23	2	IPR002464
Domain	VWFC_1	MUC5AC VWF	8.91e-04	36	23	2	PS01208
Domain	DEAH_ATP_HELICASE	CHD3 CHD4	9.93e-04	38	23	2	PS00690
Domain	PX	PIK3C2A PIK3C2B	1.33e-03	44	23	2	SM00312
Domain	PX	PIK3C2A PIK3C2B	1.65e-03	49	23	2	PF00787
Domain	PX	PIK3C2A PIK3C2B	1.71e-03	50	23	2	PS50195
Domain	-	PIK3C2A PIK3C2B	1.78e-03	51	23	2	3.30.1520.10
Domain	Phox	PIK3C2A PIK3C2B	1.85e-03	52	23	2	IPR001683
Domain	HMG_box_dom	CHD3 CHD4	2.88e-03	65	23	2	IPR009071
Domain	EGF_3	TNR SNED1 LTBP1	2.89e-03	235	23	3	PS50026
Domain	EGF_1	TNR SNED1 LTBP1	3.64e-03	255	23	3	PS00022
Pathway	REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	CHD3 CHD4	6.57e-04	27	20	2	MM15537
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	CHD3 CHD4	7.59e-04	29	20	2	MM15340
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	PIK3C2A TNR PIK3C2B VWF	7.63e-04	302	20	4	M39719
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	CHD3 CHD4	8.12e-04	30	20	2	M27637
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION	CHD3 CHD4	8.68e-04	31	20	2	M48258
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	PIK3C2A TNR PIK3C2B VWF	1.01e-03	326	20	4	MM15917
Pathway	WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA	CHD3 CHD4	1.24e-03	37	20	2	M39756
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	KDM2A CHD3 CHD4	1.84e-03	175	20	3	MM14941
Pathway	WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY	PIK3C2A PIK3C2B	1.91e-03	46	20	2	M48317
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	CHD3 CHD4	1.99e-03	47	20	2	MM15428
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	CHD3 CHD4	1.99e-03	47	20	2	M1095
Pathway	WP_PHOSPHOINOSITIDES_METABOLISM	PIK3C2A PIK3C2B	2.16e-03	49	20	2	M40046
Pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	PIK3C2A PIK3C2B	2.25e-03	50	20	2	MM14641
Pathway	REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	PIK3C2A PIK3C2B	2.52e-03	53	20	2	M662
Pathway	KEGG_INOSITOL_PHOSPHATE_METABOLISM	PIK3C2A PIK3C2B	2.62e-03	54	20	2	M3896
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	CHD3 CHD4	2.71e-03	55	20	2	MM14932
Pubmed	Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.	CHD3 CHD4	4.56e-07	2	24	2	7560064
Pubmed	The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells.	PIK3C2A PIK3C2B	4.56e-07	2	24	2	30374841
Pubmed	Class II phosphatidylinositol 3-kinase α and β isoforms are required for vascular smooth muscle Rho activation, contraction and blood pressure regulation in mice.	PIK3C2A PIK3C2B	4.56e-07	2	24	2	32192434
Pubmed	Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation.	PIK3C2A PIK3C2B	4.56e-07	2	24	2	14563213
Pubmed	Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development.	CHD3 CHD4	4.56e-07	2	24	2	35568926
Pubmed	The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.	CHD3 CHD4	4.56e-07	2	24	2	7575689
Pubmed	Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.	CHD3 CHD4	4.56e-07	2	24	2	8843877
Pubmed	Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.	PIK3C2A PIK3C2B	1.37e-06	3	24	2	23320105
Pubmed	Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β.	PIK3C2A PIK3C2B	1.37e-06	3	24	2	22128329
Pubmed	The chromatin-remodeling enzyme CHD3 plays a role in embryonic viability but is dispensable for early vascular development.	CHD3 CHD4	1.37e-06	3	24	2	32658897
Pubmed	The molecular mechanisms mediating class II PI 3-kinase function in cell physiology.	PIK3C2A PIK3C2B	1.37e-06	3	24	2	33387369
Pubmed	The class II PI 3-kinase, PI3KC2α, links platelet internal membrane structure to shear-dependent adhesive function.	PIK3C2A PIK3C2B	1.37e-06	3	24	2	25779105
Pubmed	Characterization of the CHD family of proteins.	CHD3 CHD4	2.74e-06	4	24	2	9326634
Pubmed	Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice.	PIK3C2A PIK3C2B	2.74e-06	4	24	2	30476019
Pubmed	Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis.	PIK3C2A PIK3C2B	2.74e-06	4	24	2	24098492
Pubmed	NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.	CHD3 CHD4	2.74e-06	4	24	2	16574654
Pubmed	Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.	PIK3C2A PIK3C2B	4.56e-06	5	24	2	10805725
Pubmed	Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.	PIK3C2A PIK3C2B	4.56e-06	5	24	2	20197460
Pubmed	Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity.	CHD3 CHD4	6.83e-06	6	24	2	17626165
Pubmed	Mammalian chromodomain proteins: their role in genome organisation and expression.	CHD3 CHD4	1.27e-05	8	24	2	10655032
Pubmed	The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1.	PIK3C2A PIK3C2B	2.05e-05	10	24	2	8636073
Pubmed	Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells.	PIK3C2A PIK3C2B	2.05e-05	10	24	2	8798481
Pubmed	Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity.	PIK3C2A PIK3C2B	2.05e-05	10	24	2	9247029
Pubmed	HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells.	PIK3C2A PIK3C2B	2.50e-05	11	24	2	9708406
Pubmed	HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line.	PIK3C2A PIK3C2B	2.50e-05	11	24	2	10985305
Pubmed	Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells.	PIK3C2A PIK3C2B	2.50e-05	11	24	2	12584329
Pubmed	Ligands of CD4 inhibit the association of phospholipase Cgamma1 with phosphoinositide 3 kinase in T cells: regulation of this association by the phosphoinositide 3 kinase activity.	PIK3C2A PIK3C2B	2.50e-05	11	24	2	9808187
Pubmed	Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.	CHD3 CHD4	2.50e-05	11	24	2	10204490
Pubmed	HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways.	PIK3C2A PIK3C2B	2.50e-05	11	24	2	16081599
Pubmed	NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.	CHD3 CHD4	3.00e-05	12	24	2	22560079
Pubmed	HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes.	PIK3C2A PIK3C2B	3.00e-05	12	24	2	10208934
Pubmed	Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.	PIK3C2A PIK3C2B	3.00e-05	12	24	2	14602571
Pubmed	Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells.	PIK3C2A PIK3C2B	3.00e-05	12	24	2	16514418
Pubmed	Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism.	PIK3C2A PIK3C2B	3.00e-05	12	24	2	12077252
Pubmed	Down-regulation of LFA-1-mediated T cell adhesion induced by the HIV envelope glycoprotein gp160 requires phosphatidylinositol-3-kinase activity.	PIK3C2A PIK3C2B	3.00e-05	12	24	2	9341793
Pubmed	NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.	CHD3 CHD4	3.00e-05	12	24	2	9885572
Pubmed	Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages.	PIK3C2A PIK3C2B	3.00e-05	12	24	2	12551992
Pubmed	HIV-1 Nef in macrophage-mediated disease pathogenesis.	PIK3C2A PIK3C2B	3.54e-05	13	24	2	23215766
Pubmed	LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.	CHD3 CHD4	3.54e-05	13	24	2	19703393
Pubmed	Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells.	PIK3C2A PIK3C2B	3.54e-05	13	24	2	9394803
Pubmed	The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny.	CHD3 CHD4	4.13e-05	14	24	2	17360773
Pubmed	MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.	CHD3 CHD4	4.13e-05	14	24	2	16428440
Pubmed	Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line.	PIK3C2A PIK3C2B	4.13e-05	14	24	2	17157319
Pubmed	NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.	CHD3 CHD4	4.13e-05	14	24	2	25150861
Pubmed	Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA.	CHD3 CHD4	4.13e-05	14	24	2	20585571
Pubmed	HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex.	PIK3C2A PIK3C2B	4.77e-05	15	24	2	18854243
Pubmed	Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex.	CHD3 CHD4	4.77e-05	15	24	2	9804427
Pubmed	DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression.	CHD3 CHD4	4.77e-05	15	24	2	35695185
Pubmed	NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development.	CHD3 CHD4	4.77e-05	15	24	2	19927129
Pubmed	RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation.	CHD3 CHD4	5.44e-05	16	24	2	30760870
Pubmed	HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45.	PIK3C2A PIK3C2B	5.44e-05	16	24	2	16524887
Pubmed	p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis.	CHD3 CHD4	5.44e-05	16	24	2	21930775
Pubmed	Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders.	PIK3C2A PIK3C2B	5.44e-05	16	24	2	20818790
Pubmed	HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway.	PIK3C2A PIK3C2B	5.44e-05	16	24	2	11289809
Pubmed	Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice.	PIK3C2A PIK3C2B	5.44e-05	16	24	2	20019835
Pubmed	Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.	PIK3C2A PIK3C2B	5.44e-05	16	24	2	21029719
Pubmed	Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes.	PIK3C2A PIK3C2B	6.17e-05	17	24	2	23251686
Pubmed	Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways.	PIK3C2A PIK3C2B	6.17e-05	17	24	2	12960231
Pubmed	Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.	PIK3C2A PIK3C2B	6.17e-05	17	24	2	18453587
Pubmed	A Functional Switch of NuRD Chromatin Remodeling Complex Subunits Regulates Mouse Cortical Development.	CHD3 CHD4	6.17e-05	17	24	2	27806305
Pubmed	HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway.	PIK3C2A PIK3C2B	6.94e-05	18	24	2	12526811
Pubmed	Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development.	CHD3 CHD4	6.94e-05	18	24	2	23201013
Pubmed	Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.	CHD3 CHD4	6.94e-05	18	24	2	10444591
Pubmed	The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.	CHD3 CHD4	6.94e-05	18	24	2	9790534
Pubmed	A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.	CHD3 CHD4	6.94e-05	18	24	2	12493763
Pubmed	LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.	CHD3 CHD4	6.94e-05	18	24	2	19497860
Pubmed	Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.	PCSK5 LTBP1 VWF	7.31e-05	118	24	3	21078624
Pubmed	HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.	PIK3C2A PIK3C2B	7.75e-05	19	24	2	24073214
Pubmed	Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.	PIK3C2A PIK3C2B	9.51e-05	21	24	2	9446795
Pubmed	Maternal hypervitaminosis D reduces fetal bone mass and mineral acquisition and leads to neonatal lethality.	CASR ENPP1	9.51e-05	21	24	2	23895994
Pubmed	HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells.	PIK3C2A PIK3C2B	1.05e-04	22	24	2	11994280
Pubmed	HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.	PIK3C2A PIK3C2B	1.05e-04	22	24	2	11154208
Pubmed	HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway.	PIK3C2A PIK3C2B	1.14e-04	23	24	2	23301033
Pubmed	Phosphoinositide 3-kinase-dependent inhibition of dendritic cell interleukin-12 production by Giardia lamblia.	PIK3C2A PIK3C2B	1.14e-04	23	24	2	19047410
Pubmed	Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120.	PIK3C2A PIK3C2B	1.36e-04	25	24	2	15689238
Pubmed	Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.	PIK3C2A PIK3C2B	1.36e-04	25	24	2	17632570
Pubmed	HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway.	PIK3C2A PIK3C2B	1.59e-04	27	24	2	11156964
Pubmed	Characterization of long cDNA clones from human adult spleen.	KDM2A SEMA3G	2.38e-04	33	24	2	11214971
Pubmed	Identification of the BRD1 interaction network and its impact on mental disorder risk.	CHD3 CHD4	2.68e-04	35	24	2	27142060
Pubmed	Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.	CHD3 CHD4	3.16e-04	38	24	2	33283408
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	PIK3C2A KDM2A CHD4 VWF	3.49e-04	497	24	4	23414517
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	PIK3C2A CHD3 CHD4	3.57e-04	202	24	3	24639526
Pubmed	PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex.	CHD3 CHD4	3.68e-04	41	24	2	22720776
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	ARHGAP45 CHD3 LTBP1 CHD4	4.54e-04	533	24	4	30554943
Pubmed	Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.	AFM VWF	4.84e-04	47	24	2	14760718
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	PCSK5 LTBP1 VWF	6.49e-04	248	24	3	24006456
Pubmed	Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).	KDM2A CHD3	6.63e-04	55	24	2	27114453
Pubmed	Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.	CHD3 CHD4	6.87e-04	56	24	2	26919559
Cytoband	2q37.3	RTP5 SNED1	7.48e-04	77	24	2	2q37.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q21	PCSK5 KIF27	4.85e-03	199	24	2	chr9q21
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	RTP5 SNED1	6.20e-03	226	24	2	chr2q37
Cytoband	Ensembl 112 genes in cytogenetic band chr12p13	CHD4 VWF	1.46e-02	353	24	2	chr12p13
GeneFamily	Phosphatidylinositol 3-kinase subunits	PIK3C2A PIK3C2B	2.92e-05	8	19	2	831
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 CHD4	6.86e-05	12	19	2	1305
GeneFamily	PHD finger proteins	KDM2A CHD3 CHD4	1.09e-04	90	19	3	88
GeneFamily	Fibronectin type III domain containing	TNR SNED1	1.21e-02	160	19	2	555
Coexpression	NABA_ECM_GLYCOPROTEINS	TNR SNED1 LTBP1 VWF TECTA	5.90e-07	191	23	5	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	TNR SNED1 LTBP1 VWF TECTA	6.70e-07	196	23	5	M3008
Coexpression	NABA_MATRISOME	PCSK5 TNR SNED1 MUC5AC LTBP1 SEMA3G VWF TECTA	1.36e-06	1008	23	8	MM17056
Coexpression	NABA_MATRISOME	PCSK5 TNR SNED1 MUC5AC LTBP1 SEMA3G VWF TECTA	1.56e-06	1026	23	8	M5889
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL	PCSK5 PIK3C2B LTBP1 SEMA3G	2.92e-06	115	23	4	M45752
Coexpression	NABA_CORE_MATRISOME	TNR SNED1 LTBP1 VWF TECTA	3.23e-06	270	23	5	MM17057
Coexpression	NABA_CORE_MATRISOME	TNR SNED1 LTBP1 VWF TECTA	3.53e-06	275	23	5	M5884
Coexpression	TRAVAGLINI_LUNG_ARTERY_CELL	PCSK5 PIK3C2B LTBP1 SEMA3G	4.90e-06	131	23	4	M41662
Coexpression	GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP	PCNX3 SNED1 CHD4 VWF	2.60e-05	200	23	4	M9380
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL	PCSK5 PIK3C2B LTBP1 SEMA3G	1.04e-04	286	23	4	M45746
Coexpression	OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP	PCNX3 KDM2A CHD4	2.76e-04	146	23	3	M41190
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	PCSK5 PIK3C2B LTBP1 SEMA3G VWF	5.35e-08	192	24	5	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK5 PIK3C2B LTBP1 SEMA3G VWF	5.92e-08	196	24	5	cf7f384c1771274e766bab03ecc3dfbd13f2df60
ToppCell	distal-2-Endothelial-Artery\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PCSK5 PIK3C2B LTBP1 SEMA3G VWF	6.39e-08	199	24	5	fa8aaf7a90699e41a7a4cee5614f8c9248110327
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Artery\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PCSK5 PIK3C2B LTBP1 SEMA3G VWF	6.55e-08	200	24	5	34b279804475ea58fbb052b96f44128c082627a9
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PCSK5 PIK3C2B LTBP1 SEMA3G VWF	6.55e-08	200	24	5	8552cc7a439449b30b59760c3e8667217b9852b5
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PCSK5 PIK3C2B LTBP1 SEMA3G VWF	6.55e-08	200	24	5	45c08f1befe78553bbadcc2fcffb6138306638f3
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PIK3C2B FAM153B SEMA3G VWF	1.44e-06	157	24	4	275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PCSK5 PIK3C2B SEMA3G VWF	1.63e-06	162	24	4	25bb1b9709f960fdf90faff56e874f52a8f5d17e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2A PIK3C2B SNED1 SEMA3G	1.93e-06	169	24	4	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PCSK5 PIK3C2B SEMA3G VWF	2.11e-06	173	24	4	3a9e9a09b3eeb37cbe56d650e112a8398879477f
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PCSK5 PIK3C2B SEMA3G VWF	2.31e-06	177	24	4	5ff8dcfb030312126695d53a026d2e104a401b83
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCSK5 PIK3C2A PIK3C2B SEMA3G	2.42e-06	179	24	4	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCSK5 PIK3C2B SEMA3G VWF	2.42e-06	179	24	4	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK5 PIK3C2B SEMA3G VWF	2.42e-06	179	24	4	d2db9e70b780643f1e004c41a70464d0abe26088
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 PIK3C2B SEMA3G VWF	2.53e-06	181	24	4	4ea02344e1996f264dd5e14f3b19c8782ce41699
ToppCell	Endothelial-E\|World / shred on cell class and cell subclass (v4)	PCSK5 LTBP1 SEMA3G VWF	2.70e-06	184	24	4	b4c561924c508536fd2112e91e32176b95fdf63a
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PIK3C2B LTBP1 SEMA3G VWF	2.70e-06	184	24	4	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK5 PIK3C2B LTBP1 VWF	2.82e-06	186	24	4	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	PCSK5 PIK3C2B SEMA3G VWF	2.88e-06	187	24	4	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	PIK3C2B LTBP1 SEMA3G VWF	2.94e-06	188	24	4	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 PIK3C2B SEMA3G VWF	3.00e-06	189	24	4	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 PIK3C2B SEMA3G VWF	3.00e-06	189	24	4	9da012fdfa9a8d488cab710a463a1d70e89f990c
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK5 PIK3C2B LTBP1 VWF	3.06e-06	190	24	4	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CASR LTBP1 SEMA3G VWF	3.13e-06	191	24	4	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 PIK3C2B SEMA3G VWF	3.13e-06	191	24	4	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 LTBP1 SEMA3G VWF	3.13e-06	191	24	4	b270c3dd5952f56b9bdceabe13e298fe6757563b
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK5 PIK3C2B LTBP1 VWF	3.13e-06	191	24	4	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PCSK5 PIK3C2B LTBP1 SEMA3G	3.19e-06	192	24	4	aedddccacf60e884af044cefba6c64ca10ac97d2
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 PIK3C2B SEMA3G VWF	3.19e-06	192	24	4	285a9d332a1e07b94f222d4b518dd56928b9e075
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PCSK5 PIK3C2B LTBP1 SEMA3G	3.19e-06	192	24	4	389d5e6d0689371bfe1d0b06e92e0e6e5573567b
ToppCell	IPF-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	PCSK5 PIK3C2B LTBP1 SEMA3G	3.19e-06	192	24	4	e911e286da26202853f9650ba3cdefe5a5c9b585
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 PIK3C2B SEMA3G VWF	3.19e-06	192	24	4	56b021c297a21dff357531f21e2464f85186106d
ToppCell	IPF-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	PIK3C2B LTBP1 SEMA3G VWF	3.26e-06	193	24	4	70a9aadda83a97e06e9bc2d1327ce60dd3c58767
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SNED1 LTBP1 SEMA3G	3.26e-06	193	24	4	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	IPF-Endothelial-VE_Arterial\|IPF / Disease state, Lineage and Cell class	PIK3C2B LTBP1 SEMA3G VWF	3.26e-06	193	24	4	bf83b1fe9d38408f30eee4eb634341c04ef82791
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 LTBP1 SEMA3G VWF	3.26e-06	193	24	4	58c590dd6f21bc7ae58ae1729dd574c0f1069592
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 PIK3C2B SEMA3G VWF	3.40e-06	195	24	4	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SNED1 SEMA3G VWF	3.40e-06	195	24	4	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SNED1 SEMA3G VWF	3.47e-06	196	24	4	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-B_(Artery)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	PCSK5 PIK3C2B LTBP1 SEMA3G	3.47e-06	196	24	4	f540cf17b4405a6dd38d2b6123e6541d0aac889e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SNED1 SEMA3G VWF	3.47e-06	196	24	4	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2A PIK3C2B SEMA3G VWF	3.47e-06	196	24	4	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2A PIK3C2B SEMA3G VWF	3.47e-06	196	24	4	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PIK3C2B LTBP1 SEMA3G VWF	3.54e-06	197	24	4	56afed433887cb2766eb30f22aec195148db33ab
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PIK3C2B ENPP1 SEMA3G VWF	3.61e-06	198	24	4	88b4662be9cc933a402c52673fa5e00fa979c0db
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 LTBP1 SEMA3G VWF	3.61e-06	198	24	4	5e781583908c4ee107d986904a646a7c6b8e3591
ToppCell	proximal-Endothelial-Artery\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TEX29 PIK3C2B SEMA3G VWF	3.61e-06	198	24	4	0e5572298676b6c2a2b1a77967574020b664aebd
ToppCell	proximal-3-Endothelial-Artery\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TEX29 PIK3C2B SEMA3G VWF	3.61e-06	198	24	4	946f72b594d22ae7b8e4c22483814c284cb43eea
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIK3C2B LTBP1 SEMA3G VWF	3.61e-06	198	24	4	55378e15360f867c9500b03293814965562ae55d
ToppCell	proximal-Endothelial-Artery-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TEX29 PIK3C2B SEMA3G VWF	3.61e-06	198	24	4	a56b80bdc824e4cc60366f273fb616cd0efec456
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 PIK3C2B SEMA3G VWF	3.68e-06	199	24	4	a3ec743b978ba8fdf1677b4971b5731f50ddd30f
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TEX29 PIK3C2B SEMA3G VWF	3.68e-06	199	24	4	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 PIK3C2B SEMA3G VWF	3.68e-06	199	24	4	9b02acae6325b0ac9642438a4431285ff396e5fe
ToppCell	distal-Endothelial-Artery\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PCSK5 PIK3C2B SEMA3G VWF	3.68e-06	199	24	4	b6e9aaac047d4b64b9d97f5e174e89a424d8b36d
ToppCell	distal-Endothelial-Artery-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PCSK5 PIK3C2B SEMA3G VWF	3.68e-06	199	24	4	3788f3218356aaaa10684e48d63757037f8a3a3c
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PIK3C2B LTBP1 SEMA3G VWF	3.76e-06	200	24	4	ac6b8bc9998d303f788511b8f111e682ea9f3df8
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	PCSK5 PIK3C2B LTBP1 VWF	3.76e-06	200	24	4	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PCSK5 PIK3C2B LTBP1 VWF	3.76e-06	200	24	4	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PCSK5 PIK3C2B LTBP1 VWF	3.76e-06	200	24	4	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	PCSK5 PIK3C2B LTBP1 VWF	3.76e-06	200	24	4	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PCSK5 PIK3C2B LTBP1 VWF	3.76e-06	200	24	4	ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PIK3C2B SEMA3G VWF	7.12e-05	151	24	3	3b4c57bad61e17a573e6f8dc6b917fba5fd56c43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK5 SEMA3G VWF	7.55e-05	154	24	3	e51a5114f0ec38f997f5b8bbf3a7770f98595474
ToppCell	10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3\|bone_marrow / Manually curated celltypes from each tissue	TNR ENPP1 SPAG1	7.70e-05	155	24	3	83430a64c2cb5ad29caa3dacba76c28dd204ac40
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PCSK5 TNR SNED1	7.99e-05	157	24	3	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PCNX3 ENPP1 AASDH	8.46e-05	160	24	3	8374ae912337947b2cc8d17d5840f306361fe1ff
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PIK3C2B SEMA3G VWF	9.10e-05	164	24	3	3cd80e6275f0f9b5667912139d15ebf5e6b17f2f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2A PIK3C2B VWF	9.26e-05	165	24	3	a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SEMA3G VWF	9.43e-05	166	24	3	7a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SEMA3G VWF	9.43e-05	166	24	3	bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|Liver / Manually curated celltypes from each tissue	SNED1 FAM153B AASDH	9.43e-05	166	24	3	9afa33b5ad27dc33576be592f9b22d8161366838
ToppCell	P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PCNX3 ARHGAP45 PIK3C2B	9.60e-05	167	24	3	5c3d0763f73628c71c71f9883556bb4f1639f3cc
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PIK3C2B SEMA3G VWF	9.94e-05	169	24	3	337be3bf485b54afad86e256cb0c4c1d0c2a9a2a
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)\|356C / Donor, Lineage, Cell class and subclass (all cells)	PIK3C2B SEMA3G VWF	9.94e-05	169	24	3	605cc2638271803cf1d972ab3fa8f13f89666376
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PIK3C2B SEMA3G VWF	1.05e-04	172	24	3	de9b11ab109d04937186c09772cec9105a935f95
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNED1 LTBP1 TECTA	1.05e-04	172	24	3	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PCSK5 SEMA3G VWF	1.07e-04	173	24	3	b0ff9808e38cb64a734ced498cd0546728746cd5
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	PIK3C2B SEMA3G VWF	1.07e-04	173	24	3	22200fe74e33e2beae0eed289ca8476bbc0b1b2d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP45 TNR SNED1	1.07e-04	173	24	3	afa6bb19df52541d8d17cbfac9cbdd18a5f3632d
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	PIK3C2B SEMA3G VWF	1.07e-04	173	24	3	ec88e871b49331fca59bc610a8ae58e2d5e76bc1
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 SEMA3G VWF	1.08e-04	174	24	3	40bb87d219aafab0357ab0d797efd38085fc0312
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-E\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ENPP1 SEMA3G VWF	1.08e-04	174	24	3	4a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK5 PIK3C2B SEMA3G	1.08e-04	174	24	3	18ab52d8bbca0507fee220e0c4fc765fc47dda34
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP45 PIK3C2B SPAG1	1.08e-04	174	24	3	ce9bdd02dc8eb45ba9c1481619c0089b465e6442
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	PIK3C2B SEMA3G VWF	1.10e-04	175	24	3	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	SNED1 ENPP1 LTBP1	1.12e-04	176	24	3	ce2c32b5ce0da848eb4da35ce4d215cdf74d9113
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SEMA3G VWF	1.12e-04	176	24	3	77516048aefbe1f48e825052756df0c310c1c486
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SEMA3G VWF	1.12e-04	176	24	3	96779273b94345250cf53ba671203345b43d9e00
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SEMA3G VWF	1.12e-04	176	24	3	27e6b3ae41068d6cfdda3d46da7df2a27567140e
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SEMA3G VWF	1.12e-04	176	24	3	d6a5470af9592f34a741265f2ea9651c05c3add3
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNR SEMA3G VWF	1.14e-04	177	24	3	16197068260fc062bf8b730a51a199887ea580b9
ToppCell	367C-Endothelial_cells-Endothelial-B_(Artery)\|367C / Donor, Lineage, Cell class and subclass (all cells)	PIK3C2B SEMA3G VWF	1.16e-04	178	24	3	e1e96a0e3ff718ebf676a982bc63e8ced6984059
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SEMA3G VWF	1.16e-04	178	24	3	5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PIK3C2B SEMA3G VWF	1.16e-04	178	24	3	c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCell	367C-Endothelial_cells-Endothelial-B_(Artery)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	PIK3C2B SEMA3G VWF	1.16e-04	178	24	3	363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e
ToppCell	droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LTBP1 SEMA3G VWF	1.18e-04	179	24	3	b7281160c84dd053a2981c9c76ea6cc6d2592cd5
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 SEMA3G VWF	1.20e-04	180	24	3	67c5068b660cd5e727a665cefe3bd5f8ae887221
ToppCell	Endothelial-A-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	TNR SEMA3G VWF	1.20e-04	180	24	3	4c3376169770ee9f9283daae44c17f35e46bfd19
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 PIK3C2B VWF	1.22e-04	181	24	3	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SEMA3G VWF	1.22e-04	181	24	3	4d7793026373cbcf04b15c77f95f1025d07d4c00
Disease	eosinophil percentage of leukocytes	ARHGAP45 PIK3C2B MUC5AC CASR KIF27	1.48e-04	746	21	5	EFO_0007991
Disease	end stage renal disease (is_implicated_in)	ENPP1 VWF	3.89e-04	41	21	2	DOID:783 (is_implicated_in)
Disease	end stage renal disease (is_marker_for)	CASR VWF	4.90e-04	46	21	2	DOID:783 (is_marker_for)
Disease	pulmonary fibrosis (biomarker_via_orthology)	MUC5AC VWF	5.79e-04	50	21	2	DOID:3770 (biomarker_via_orthology)
Disease	mean platelet volume	PCNX3 ARHGAP45 CASR LTBP1 VWF	6.27e-04	1020	21	5	EFO_0004584
Disease	PROSTATE CANCER, HEREDITARY, 1	KDM2A CHD3	8.33e-04	60	21	2	C4722327
Disease	interstitial lung disease	MUC5AC SPAG1	1.04e-03	67	21	2	EFO_0004244
Disease	Prostate cancer, familial	KDM2A CHD3	1.10e-03	69	21	2	C2931456

Protein segments in the cluster

Peptide	Gene	Start	Entry
YDGCCEGDVVQCIRD	AFM	266	P43652
CCFECVECPDGEYSD	CASR	561	P41180
CCSQYICIGCVDGNL	AASDH	946	Q4L235
VYFQGAECEECCLAC	ARHGAP45	721	Q92619
GECLGYQCCVEEAFT	KIF27	406	Q86VH2
AITEGVEEDEGCCCC	PCNX3	1416	Q9H6A9
DYEECVPCEEGCLGC	PCSK5	1031	Q92824
CVRVQEGYTCDCFDG	LTBP1	1636	Q14766
CAGCCVATYVLGICD	PIK3C2A	1236	O00443
CVELGNCCLDYQETC	ENPP1	126	P22413
CQSCLCTERGVECTY	MUC5AC	1256	P98088
CAGCCVATYVLGICD	PIK3C2B	1181	O00750
ACVQGECGVCHYCRD	KDM2A	576	Q9Y2K7
YCEVCQQGGEIILCD	CHD3	381	Q12873
DYCEVCQQGGEIILC	CHD4	371	Q14839
MGCAYSCCLEVCCGE	FAM153B	1	P0C7A2
SCCLEVCCGEDEIVY	FAM153B	6	P0C7A2
EGCCEACELGVCFLQ	RTP5	141	Q14D33
AVCVCQAGYTGAACE	SNED1	371	Q8TER0
CTVQCLCEEGGDVYC	TECTA	671	O75443
CESIGDCACFCDTIA	VWF	1091	P04275
CYLKEGNCSGCIQDC	SPAG1	496	Q07617
RGVCVDGQCICDSEY	TNR	211	Q92752
QCETYGTACAECCLA	SEMA3G	521	Q9NS98
DRCQELGCCFYEGVC	TEX29	36	Q8N6K0